
STAT+: In first big randomized trial, Abiomed’s heart pump reduced deaths in heart attack patients
A controversial heart pump from Abiomed reduced the number of deaths in severe heart attack…

A controversial heart pump from Abiomed reduced the number of deaths in severe heart attack…

ATLANTA — Beta blockers are a mainstay in cardiovascular treatment, frequently given to patients after…

ATLANTA — New trial results show that a drug candidate from Alnylam Pharmaceuticals can lead…

ATLANTA — Novo Nordisk’s Wegovy improved symptoms and physical function in patients who had obesity,…